Hematology/Oncology Associates of Central New York
East Syracuse, New York 13057
5 studies enrolling now · 18 studies all time
What they study most
Acinar Cell Carcinoma, Adenocarcinoma of the Colon, Advanced Cancer, Advanced Solid Tumor, B-Cell Non-Hodgkins Lymphoma, Bladder Cancer, Breast Cancer, Carcinoma, Pancreatic Ductal, Chronic Lymphocytic Leukemia (CLL), Colorectal Cancer, Coronavirus, Effect of Drug
Studies at this site
- A Study to Evaluate Glofitamab as a Single Agent vs. Investigator's Choice in Participants With Relapsed/Refractory Mantle Cell Lymphoma — Recruiting now
- A Study of ART0380 for the Treatment of Advanced or Metastatic Solid Tumors — Recruiting now
- A Study to Evaluate the Optimization of the Cytokine Release Syndrome Profile for Glofitamab in Combination With Gemcitabine Plus Oxaliplatin in Participants With Relapsed/Refractory Aggressive B-Cell Non-Hodgkin's Lymphoma — Recruiting now
- GEMINI-NSCLC: NSCLC Biomarker Study — Recruiting now
- Comparison of Combination Chemotherapy Regimens With or Without Cetuximab in Treating Patients Who Have Undergone Surgery For Stage III Colon Cancer — Completed
- The Active After Cancer Trial (AACT) — Running, not enrolling
- Impact of a Health Technology Intervention on Patient Activation in Multiple Myeloma — Running, not enrolling
- A Phase 1/2a Study of IMM-1-104 in Participants With Advanced or Metastatic Solid Tumors — Running, not enrolling
- Electronic Patient Reporting of Symptoms During Cancer Treatment — Completed
- PFA 100 Evaluation and Reference Interval HOACNY — Enrolling by invitation
- Prospective Clinicogenomic Program — Completed
- A Study of Napabucasin Plus Nab-Paclitaxel With Gemcitabine in Adult Patients With Metastatic Pancreatic Adenocarcinoma — Completed
- ASCO Survey on COVID-19 in Oncology (ASCO) Registry — Status unconfirmed
- Blood Sample Collection to Evaluate Biomarkers in Subjects With Untreated Solid Tumors — Completed
- informCLL™: A Disease Registry for Patients With Chronic Lymphocytic Leukemia — Completed
- NBRST: Prospective Neo-adjuvant REGISTRY Trial — Completed
- Alternative Approaches for Nausea Control — Completed
- Safety Study of TAK-700 in Subjects With Prostate Cancer. — Completed